期刊文献+

依卡倍特钠的核磁共振数据解析 被引量:2

Assignment of Chemical Shift of Ecabet Sodium
下载PDF
导出
摘要 依卡倍特钠是日本田边公司生产的一种具有覆盖作用的抗胃炎、胃溃疡的新型药物。笔者对依卡倍特钠进行了1H NMR、13C NMR检测,并通过DEPT、gCOSY、gHMQC、gHMBC等2DNMR技术对其NMR数据进行较为详细的解析和NMR信号全归属,为今后的分析鉴定工作提供完善的NMR数据。 Ecabet sodium is a new drug for treating gastric ulcer and gastritis invented by JapanTanabe Seiyaku Company. Its major function is to protect gastric mucosal via its adherence to the gastric mucosa ,enhancing gastric mucosal defensive ability and the defensive factors such as the endogenous prostaglandins. The IH NMR and ^13C NMR spectra of ecabet sodium were acquired, completely assigned and analyzed by a combination of ID (1H NMR, ^13C NMR and DEPT) and 2D NMR (1H-1H COSY, HMQC and HMBC) techniques. The results obtained provided a reference for characterization of similar compounds in the future.
出处 《精细化工中间体》 CAS 2008年第5期65-67,共3页 Fine Chemical Intermediates
关键词 药物化学 依卡倍特钠 NMR解析 medicinal chemistry ecabet sodium NMR analysis
  • 相关文献

参考文献5

  • 1张元庆 李娜 韦舒静 等.伊卡倍特钠治疗糜烂性胃炎组织学愈合质量的观察.当代医学,2007,112(02):13-15.
  • 2王惠吉,于中麟,林三仁,周丽雅,钱家鸣,刘晓红,程留芳,孙国辉,黄乃侠,吕宗舜.依卡倍特钠治疗胃溃疡及胃炎的疗效和安全性[J].中国新药杂志,2005,14(8):1045-1048. 被引量:13
  • 3Matsui S, Kudo M, Okada M, et al. S1640 combination therapy of ecabet sodium and proton pump inhibitor (PPI) compared with PPI alone for endoscopic submucosal dissection (ESD) -induced ulcer in gastric cancer: prospective randomized study[J]. Gastroenterology, 2008, 134 (4): A-240.
  • 4Matsumoto Y, Ito M, Haruma K, et al. Effect of ecabet sodium on gastric adaptive relaxation and intragastric pressure [J]. Gastrointestinal Endoscopy, 2007, 65 (5): AB183.
  • 5Sasaki K, Iizuka M, Konno S, et al. Ecabet sodium improves clinical symptoms and QOL of Crohn's disease [J]. Gastroenterology, 2003, 124 (4): A204.

二级参考文献6

  • 1Inane M, Matsumoto N, Suenaga T, et al. Effects of the antiulcer agent TA-2711 on basal secretion in the human stomach[J]. Prog Med,1991,11:327- 334.
  • 2Misawa T, Chijiiwa Y, Fujishima H, et al. Binding of TA-7211, a novel therapeutic agent for gastric ulcers, to gastric ulcer lesions[ J]. J New Rem Clin ( Shin-yaku to Rinshou ), 1991,40:727 - 732.
  • 3Asada S,Takiuchi H,Tei H, et al. Evaluation of an anti-ulcer drug,Ecabet Sodium(TA-2711) on covering of the gastric mucosa[J]. Jpn J Clin Exp Med,1994,71:2439- 2443.
  • 4Miyoshi A, Goto Y, Sekiguchi T, et al. Early clinical trial of the antiulcer agent TA-7211 for treatment of gastric ulcers [ J ]. Prog Med,1991,11 : 293 - 303.
  • 5Abe S, Hongo M, Yamaguchi N, et al. Studies on gastric mucosal disturbances induced by aspirin in humans-preventive effects of TA-7211 [J]. J New Rent Clin ( Shin-yaku to Rinshou ), 1991,40 : 719 -724.
  • 6Kohli Y, Kato T, suzuki K, et al. Studies on effects of 12-sulfodehydroabietic acid monosodium salt( TA-2711 ) on hexasamine and prostaglandias contents in human gastric mucosa [ J]. Kyoto Pref Univ Med, 1990,99(9) : 1085 - 1090.

共引文献12

同被引文献5

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部